{"filing":{"accession_number":"0001437749-26-029738","cik":"0001131343","ticker":"PRNAF","company_name":"ALTERITY THERAPEUTICS LTD","form":"6-K","filing_date":"2026-09-08","report_date":"2026-09-30","primary_document":"athe20260908c_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1131343/000143774926029738/athe20260908c_6k.htm"},"events":[{"id":31706,"run_id":29108,"accession_number":"0001437749-26-029738","anchor_item_number":"EX-99.1","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The Company completed issuance of 8,400,000 fully paid ordinary shares to MST Financial Services Pty Ltd and sub-underwriters pursuant to an underwriting agreement related to exercise of ATHO class options. This represents a dilutive equity issuance. The cleansing notice under section 708A(5)(e) of the Corporations Act confirms the shares were issued without disclosure to investors under Part 6D.2, which is a hallmark of unregistered or exempt equity offerings. The material scale (8.4 million shares) and capital-raising context make this material to investors.","company_name":"ALTERITY THERAPEUTICS LTD","ticker":"PRNAF","filing_date":"2026-09-08","form":"6-K","submitted_at":null,"items":[{"id":34662,"accession_number":"0001437749-26-029738","item_number":"EX-99.1","item_title":"ex_1013529.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The Company completed issuance of 8,400,000 fully paid ordinary shares to MST Financial Services Pty Ltd and sub-underwriters pursuant to an underwriting agreement related to exercise of ATHO class options. This represents a dilutive equity issuance. The cleansing notice under section 708A(5)(e) of the Corporations Act confirms the shares were issued without disclosure to investors under Part 6D.2, which is a hallmark of unregistered or exempt equity offerings. The material scale (8.4 million shares) and capital-raising context make this material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-08T10:06:14.189563+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34662,"accession_number":"0001437749-26-029738","item_number":"EX-99.1","item_title":"ex_1013529.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The Company completed issuance of 8,400,000 fully paid ordinary shares to MST Financial Services Pty Ltd and sub-underwriters pursuant to an underwriting agreement related to exercise of ATHO class options. This represents a dilutive equity issuance. The cleansing notice under section 708A(5)(e) of the Corporations Act confirms the shares were issued without disclosure to investors under Part 6D.2, which is a hallmark of unregistered or exempt equity offerings. The material scale (8.4 million shares) and capital-raising context make this material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-08T10:06:14.189563+00:00","company_name":"ALTERITY THERAPEUTICS LTD","ticker":"PRNAF","filing_date":"2026-09-08"}]}